Literature DB >> 4215671

Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone: evidence by fluorescence histochemistry.

J Constantinidis, F Geissbühler, J M Gaillard, T Hovaguimian, R Tissot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4215671     DOI： 10.1007/bf01923678

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  3 in total

1.  Effects of thyrotropin-releasing hormone in depression.

Authors:  A J Prange; P P Lara; I C Wilson; L B Alltop; G R Breese
Journal:  Lancet       Date:  1972-11-11       Impact factor: 79.321

2.  Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone.

Authors:  A J Kastin; R H Ehrensing; D S Schalch; M S Anderson
Journal:  Lancet       Date:  1972-10-07       Impact factor: 79.321

3.  Thyrotropin releasing hormone: enhancement of dopa activity by a hypothalamic hormone.

Authors:  N P Plotnikoff; A J Prange; G R Breese; M S Anderson; I C Wilson
Journal:  Science       Date:  1972-10-27       Impact factor: 47.728
  3 in total
  5 in total

1.  Thyrotropin releasing hormone: neurochemical evidence for the potentiation of imipramine effects on the metabolism and uptake of brain catecholamines.

Authors:  R B Rastogi; R L Singhal; Y D Lapierre
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

2.  Investigations into the mechanism of reduction of ethanol sleep by thyrotropin-releasing hormone (TRH).

Authors:  J M Cott; G R Breese; B R Cooper; S Barlow; A J Prange
Journal:  J Pharmacol Exp Ther       Date:  1976-03       Impact factor: 4.030

3.  The effect of highly selective inhibitors of the uptake of noradrenaline or 5-hydroxytryptamine on TRH-induced hyperthermia in mice.

Authors:  L Pawłowski; H Kwiatek
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

4.  Pituitary thyroid function and prolactin release following intravenous administration of TRH and pyroglutamyl-histidyl-prolyl-β alanine amide to healthy volunteers.

Authors:  W P Taaffe; R F Lambe; D A O'Kelly; A Darragh
Journal:  Ir J Med Sci       Date:  1979-12       Impact factor: 1.568

5.  Investigations on the interaction of thyrotropin-releasing hormone (TRH) and MK-771 with central noradrenergic mechanisms.

Authors:  V J Lotti; G G Yarbrough; B V Clineschmidt
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.